drugset
drugset / Trial / NCT04640376

Paracetamol UNIFLASH for Buccal Use Phase III Trial in Acute Pain Due to a Tooth Extraction

NCT04640376 ↗

Phase 3 Completed 407 enrolled Unither Pharmaceuticals, France AIXIAL Development · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the analgesic efficacy of single dose of a new paracetamol formulation (paracetamol UNIFLASH) for buccal use in comparison to two different doses of an oral paracetamol form controlled versus placebo.

Timeline

Start
2021-03-24
Primary completion
2022-11-08
Completion
2022-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 125 mg Other
Subject Acetaminophen Small molecule 500 mg Other
Subject Acetaminophen Small molecule 1000 mg Other

Indications

No indication recorded.